Baxter Launches IV Verify System to Automate IV Labeling and Reduce Medication Errors
Event summary
- Baxter International Inc. debuted the IV Verify Line Labeling System at the 2026 American Organization for Nursing Leadership Conference.
- The system automates IV labeling, replacing handwritten labels with standardized, barcode-scanned adhesive labels.
- A 10-hospital study found 60% of IV infusion labels non-compliant with hospital policies.
- The product is available now in the U.S. under an exclusive distribution agreement with Vigilant Software.
The big picture
Baxter’s launch of the IV Verify system addresses persistent challenges in high-acuity healthcare settings where medication errors are a critical concern. The product aligns with broader industry trends toward automation and clinician-focused innovations aimed at improving patient safety and operational efficiency. With an exclusive distribution agreement, Baxter leverages Vigilant Software’s expertise to strengthen its position in infusion therapies.
What we're watching
- Adoption Pace
- How quickly hospitals will integrate the IV Verify system into existing workflows, given its potential to reduce medication errors.
- Competitive Response
- Whether competitors will introduce similar automation solutions, pressuring Baxter on pricing or features.
- Regulatory Impact
- The extent to which the system may influence healthcare regulations around IV labeling and medication safety.
Related topics